Booz Allen Hamilton
BAH
$73.59
+3.43%
Booz Allen Hamilton Holding Corporation is a leading management and technology consulting firm that provides analytics, digital transformation, engineering, and cybersecurity solutions primarily to U.S. federal government agencies, with a growing commercial and international presence. As a premier defense and intelligence contractor, it distinguishes itself through deep domain expertise in AI, cyber, and mission-critical systems, positioning it as a strategic partner for national security initiatives. The current investor narrative centers on the Pentagon's accelerated pivot toward AI-driven autonomous systems and missile defense programs, which are expected to create high-margin revenue streams, yet the stock has faced significant volatility due to budget uncertainties and a sharp drawdown from its 52-week high, prompting debate about its growth trajectory and valuation reset.…
BAH
Booz Allen Hamilton
$73.59
Related headlines
Investment Opinion: Should I buy BAH Today?
We rate BAH a Hold. The stock is attractively valued at 11.29x trailing PE, but the revenue decline and high leverage warrant caution. The average analyst target of $85.58 implies 22.7% upside, but the consensus is Hold, reflecting uncertainty.
Sign up to view all
BAH 12-Month Price Forecast
The AI assessment is neutral with medium confidence. The stock is undervalued on a PE basis, but the revenue decline and high leverage create uncertainty. The recent earnings beat and strategic alignment with defense AI are positive, but the market's cautious stance and negative momentum suggest limited upside in the near term. A shift to bullish would require evidence of sustained revenue growth and improved analyst sentiment, while a shift to bearish would occur if budget cuts intensify or debt levels become unsustainable.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Booz Allen Hamilton's 12-month outlook, with a consensus price target around $85.58 and implied upside of +16.3% versus the current price.
Average Target
$85.58
0 analysts
Implied Upside
+16.3%
vs. current price
Analyst Count
—
covering this stock
Price Range
$68 - $140
Analyst target range
Analyst coverage includes 12 analysts, with a consensus recommendation of 'Hold' (mean rating 2.86 on a 1-5 scale, where 1 is Strong Buy and 5 is Sell). The average target price is $85.58, implying a 22.7% upside from the current price of $69.72. The distribution shows a mix of Hold and Sell ratings, with recent actions from Goldman Sachs (Sell), JP Morgan (Underweight), and Citigroup (Neutral), while Stifel upgraded to Buy in May 2026, indicating a cautious but not entirely bearish sentiment. The target range spans from a low of $68.00 to a high of $140.00, with the low near the current price, suggesting some analysts see limited downside, while the high implies a 100% upside, reflecting a wide dispersion in expectations. The wide spread indicates high uncertainty, likely due to the volatile federal budget environment and the company's recent revenue decline, but the average target still suggests meaningful upside if the company can execute on its AI and defense growth strategies.
Bulls vs Bears: BAH Investment Factors
The bull case rests on BAH's deeply discounted valuation, strategic alignment with defense AI priorities, and strong cash generation, while the bear case highlights revenue decline, high leverage, and cautious analyst sentiment. Currently, the bearish evidence is stronger given the persistent downtrend and revenue contraction, but the valuation discount and recent earnings beat suggest the downside may be limited. The most important tension is whether the revenue decline is a temporary budget hiccup or a structural shift in defense spending; if growth resumes, the stock could re-rate significantly, but if not, the low PE may be justified.
Bullish
- Deep discount to historical valuation: BAH trades at a trailing PE of 11.29x, near the bottom of its two-year range of 11.5x-37.6x and a 49% discount to the industry average of 22x. This suggests the market is pricing in excessive pessimism, offering potential upside if growth stabilizes.
- Strategic alignment with defense AI priorities: The Pentagon's pivot toward AI-driven autonomous systems and missile defense programs (e.g., Golden Dome) aligns with BAH's core expertise in AI, cyber, and mission-critical systems. This could drive high-margin revenue growth, as highlighted by recent news on defense AI supercharging.
- Recent earnings beat and strong cash flow: In Q4 FY2026, BAH beat earnings expectations, with EPS of $1.69 vs. estimates, and generated $951 million in trailing free cash flow. The stock soared on the beat, indicating operational resilience despite revenue decline.
- Low beta provides defensive characteristics: With a beta of 0.361, BAH is significantly less volatile than the market, making it a defensive play in uncertain times. This low correlation can protect portfolio value during broader market downturns.
Bearish
- Revenue decline breaks growth streak: Q4 FY2026 revenue fell 6.44% YoY to $2.783 billion, breaking a multi-quarter trend of modest growth. This deceleration in federal spending is a key concern, as it may signal a broader slowdown in defense budgets.
- High leverage and debt burden: Debt-to-equity ratio stands at 3.73, indicating significant leverage. With interest expenses of $48 million in Q4, the company is exposed to rising rates, which could pressure earnings and cash flow.
- Heavy reliance on cost-reimbursable contracts: 57.5% of revenue comes from cost-reimbursable contracts, which typically carry lower margins. This mix limits profitability upside and increases exposure to government audit adjustments.
- Negative relative strength and downtrend: The stock is down 33.29% over the past year, underperforming the S&P 500 by 51.48 percentage points. The 1-year relative strength of -51.48% indicates persistent selling pressure and a lack of investor confidence.
BAH Technical Analysis
Booz Allen Hamilton's stock is in a pronounced downtrend over the past year, with a 1-year price change of -33.29%, significantly underperforming the S&P 500's +18.19% gain. The current price of $69.72 sits at 60.9% of its 52-week range (between $59.50 low and $114.48 high), indicating it is closer to the lows than the highs, which often suggests either a value opportunity or a falling knife, depending on fundamental support. The stock has rebounded 16.18% over the past month, but remains 10.30% lower over three months and 19.95% lower over six months, reflecting a persistent bearish bias despite the recent bounce.
Beta
0.35
0.35x market volatility
Max Drawdown
-48.5%
Largest decline past year
52-Week Range
$60-$114
Price range past year
Annual Return
-34.0%
Cumulative gain past year
| Period | BAH Return | S&P 500 |
|---|---|---|
| 1m | +17.8% | +3.6% |
| 3m | -3.5% | +5.1% |
| 6m | -12.9% | +13.8% |
| 1y | -34.0% | +22.2% |
| ytd | -13.3% | +13.1% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
BAH Fundamental Analysis
Revenue in the latest quarter (Q4 FY2026, ended March 31, 2026) was $2.783 billion, a 6.44% decline year-over-year, breaking a multi-quarter trend of modest growth (Q1 FY2026: $2.924B, Q2: $2.890B, Q3: $2.620B). The revenue mix shows a heavy reliance on cost-reimbursable contracts ($1.601B, 57.5% of total), which typically carry lower margins, while fixed-price ($0.550B) and time-and-materials ($0.632B) contracts offer more upside but also more risk. The YoY decline suggests a deceleration in federal spending, which is a key concern for the investment case, though the company's focus on AI and cybersecurity aligns with long-term defense priorities.
Quarterly Revenue
$2.8B
2026-03
Revenue YoY Growth
-6.4%
YoY Comparison
Gross Margin
20.9%
Latest Quarter
Free Cash Flow
$951000000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is BAH Overvalued?
Given positive net income, the PE ratio is the primary valuation metric. The trailing PE is 11.29x, while the forward PE is 10.39x, indicating the market expects earnings growth of approximately 8.7% over the next year. This is a relatively low multiple for a consulting firm with a strong moat in defense, suggesting the market is pricing in significant risks. Compared to the industry average PE of 22x (based on historical data), BAH trades at a 49% discount, which could be justified by its recent revenue decline and high debt levels, but also presents potential upside if growth stabilizes. Historically, the stock's PE has ranged from 11.5x to 37.6x over the past two years, and the current 11.29x is near the bottom of that range, indicating the market is pricing in pessimistic expectations, possibly overdone given the company's strategic positioning.
PE
11.3x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 12x~38x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
10.5x
Enterprise Value Multiple
Investment Risk Disclosure
Financial risks are significant: BAH carries a high debt-to-equity ratio of 3.73, leading to interest expenses of $48 million in Q4, which could strain earnings if rates rise. The company's revenue declined 6.44% YoY in the latest quarter, breaking a growth streak, and its reliance on cost-reimbursable contracts (57.5% of revenue) limits margin expansion and exposes it to government audit adjustments. Free cash flow remains positive at $951 million TTM, but the high payout ratio of 32.4% and leverage could limit financial flexibility.